[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369875-105":59,"doc-detail-369875-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","characterization-of-the-immune-landscape-in-healthy-mouse-prostate-and-during-prostate-cancer-progression","Characterization of the immune landscape in healthy mouse prostate and during prostate cancer progression","","The immune landscape of healthy prostate and its alterations during prostate cancer (PCa) progression remain poorly characterized. Using scRNA-sequencing and multiparametric flow-cytometry, immune cells in wildtype and PTEN(i)pe−/− mouse prostates were comprehensively profiled. PCa in PTEN(i)pe−/− features recruitment of tumor-associated neutrophils as the dominant immune population, forming eight distinct states, along with Trem2+ tumor-associated macrophages and exhausted CD8+ T cells. Trem2+ TAMs show a strong metabolic and immunosuppressive program likely driven by the MIF/HIF1A signaling axis.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/characterization-of-the-immune-landscape-in-healthy-mouse-prostate-and-during-prostate-cancer-progression/369875/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/characterization-of-the-immune-landscape-in-healthy-mouse-prostate-and-during-prostate-cancer-progression/369875.png","ImageObject",300,407,{"name":92,"@type":93},"Aldword","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What approach is used to characterize immune cells in mouse prostate?","Question",{"text":112,"@type":113},"The study uses scRNA-sequencing together with multiparametric flow cytometry to profile immune cells in wildtype and PTEN(i)pe−/− mouse prostates.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which immune cell populations mark prostate cancer progression in the PTEN(i)pe−/− model?",{"text":117,"@type":113},"Progression is marked by recruitment of tumor-associated neutrophils (TANs), which become the dominant immune population, as well as Trem2+ tumor-associated macrophages and exhausted CD8+ T cells.",{"name":119,"@type":110,"acceptedAnswer":120},"How do Trem2+ TAMs differ and what signaling axis is implicated?",{"text":121,"@type":113},"Trem2+ TAMs differ from main resident macrophage populations in the healthy prostate, showing a strong metabolic and immunosuppressive signature likely driven by the MIF/HIF1A signaling axis.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},369875,1790534599,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},2336478940917,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","ONCOIMMUNOLOGY  \n2025, VOL. 14, NO. 1, 2562220 [https://doi.org/10.1080/2162402X.2025.2562220](https://doi.org/10.1080/2162402X.2025.2562220)  \nCharacterization of the immune landscape in healthy mouse prostate and during prostate cancer progression  \nDespoina Pervizou a, Joanna De Chiara a, Lionel Spinelli a, Maïa Nestor-Martin a, Lionel Chassona, Kateryna Len-Tayon b,c,d,e, Darya Yanushko b,c,d,e, Frédéric Fiore f, Marc Bajénoff a,  \nBernard Malissen a,f, Daniel Metzger b,c,d,e, Gilles Laverny b,c,d,e, and Sandrine Henri a*  \naAix-Marseille Université, CNRS, INSERM, CIML, Centre d’Immunologie de Marseille-Luminy, Marseille, France; bInstitut de Génétique et de Biologie Moléculaire et Cellulaire, Department of Functional Genomics and Cancer, Illkirch, France; cCentre National de la Recherche Scientifique (CNRS), Illkirch, France; dInstitut National de la Santé et de la Recherche Médicale (INSERM), Illkirch, France; e Université de Strasbourg, Strasbourg, France; fCentre d’Immunophénomique, Aix Marseille Université, INSERM, CNRS, Marseille, France  \nABSTRACT  \nThe immune landscape of healthy prostate and its alterations during prostate cancer (PCa) progression remain poorly characterized. Using scRNA-sequencing and multiparametric flow-cytometry analysis, we comprehensively characterized immune cells in wildtype and PTEN(i)pe−/− mouse prostates, a model that closely recapitulates human PCa. PCa in PTEN(i)pe−/− is marked by the recruitment of tumor-associated neutrophils (TANs), which represent the dominant immune cell population and resolved into eight distinct states, Trem2+ tumor-associated-macrophages (TAMs), and exhausted CD8+ T cells. Trem2+ TAMs differ from the three main resident macrophage populations in the healthy prostate, exhibiting a strong metabolic and immunosuppressive signature, likely driven by the MIF/HIF1A-signaling axis. This study provides the first detailed characterization of immune cells in the healthy mouse prostate and reveals changes in the immune landscape associated with prostate cancer progression.  \nSUMMARY  \nUsing scRNA-sequencing and flow cytometry, this study uncovers the immune cell landscape in healthy prostate and its dynamic changes during prostate cancer progression, identifying three resident macrophage populations and early immune alterations linked to tumor development (TAMs, TANs, Exhausted T cells) .  \nARTICLE HISTORY  \nReceived 12 March 2025 Revised 11 August 2025 Accepted 10 September 2025  \nKEYWORDS  \nProstate; PTEN(i)pe−/− prostate cancer murine model; resident macrophage subsets; Trem2+ tumorassociated-macrophages (TAM); tumor-associatedneutrophils (TAN); exhausted CD8+ T cells; scRNA-seq; multiparametric flow cytometry  \nIntroduction  \nThe prostate is an exocrine gland of the male reproductive system, composed of epithelial and few neuroendocrine cells supported by a fibroelastic stroma. 1–3 Prostate cancer (PCa) arises from the malignant transformation of prostatic luminal epithelial cells at adulthood. It is the most common visceral malignancy in men over 65 years old,4 and progresses over decades from prostatic intraepithelial neoplasia (PIN) toadenocarcinoma, eventually leading to castration-resistant metastatic prostate cancer. The human prostate has a lobular shape and is divided in three zones, whereas mouse prostate consists of four distinct lobes. Human prostate adenocarcinoma predominantly originates in the peripheral zone, which corresponds anatomically to the dorsolateral (DL) lobes in mice.  \nEpithelial and stromal cells have been studied in both human and mouse prostates, at steady-state and during PCa progression.5–8 The immune microenvironment plays a pivotal role in tumorigenesis and recent studies have begun to delineate immune alterations associated with human prostate cancer, including the involvement of myeloid-derived suppressor cells (MDSCs), immunosuppressive macrophages and  \nCONTACT Sandrine Henri  [sandrine.henri@inserm.fr](sandrine.henri@inserm.fr) ","cbCaia2sZRLeBuIO","https://ap.wps.com/l/cbCaia2sZRLeBuIO","pdf",4378429,28,"English","# Abstract\n# Summary\n# Keywords\n# Introduction","[{\"question\":\"What approach is used to characterize immune cells in mouse prostate?\",\"answer\":\"The study uses scRNA-sequencing together with multiparametric flow cytometry to profile immune cells in wildtype and PTEN(i)pe−/− mouse prostates.\"},{\"question\":\"Which immune cell populations mark prostate cancer progression in the PTEN(i)pe−/− model?\",\"answer\":\"Progression is marked by recruitment of tumor-associated neutrophils (TANs), which become the dominant immune population, as well as Trem2+ tumor-associated macrophages and exhausted CD8+ T cells.\"},{\"question\":\"How do Trem2+ TAMs differ and what signaling axis is implicated?\",\"answer\":\"Trem2+ TAMs differ from main resident macrophage populations in the healthy prostate, showing a strong metabolic and immunosuppressive signature likely driven by the MIF/HIF1A signaling axis.\"}]","Characterization of the immune landscape in healthy mouse prostate and during prostate cancer progression | PDF",1790185010,71,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/71a3ddaa7df19403afdb395c342faec4.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f23d916c4c2c40aa97bb140a2b930b23.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7f6272d570568d634457140cdb476f23.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/24b2dbee679528dcf0e656f43ac8fa8e.webp",980,1306]